Biontech SE

BNTX · NASDAQ

$91.17+$1.96 (+2.20%)TodayMarket closed ·
Prev close $89.21

Latest news

  • Press releaseGlobe Newswire

    BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026

  • Press releasePRNewswire

    BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX)

  • NewsVandana Singh

    Why Is BioNTech Stock Falling Tuesday?

  • NewsAvi Kapoor

    Syndax Pharmaceuticals, BioNTech, Seagate And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

  • Press releaseGlobe Newswire

    BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer

  • NewsNeeraj Jain

    A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally

  • NewsVandana Singh

    Invivyd Outlines Accelerated Approval Submission Path with FDA for COVID-19 Antibody

  • Press releaseGlobe Newswire

    A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat

  • NewsVandana Singh

    Why Is BioNTech Stock Gaining Monday?

  • Press releaseGlobe Newswire

    BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients

  • News

    10 Health Care Stocks With Whale Alerts In Today’s Session

  • NewsAvi Kapoor

    Take Two Interactive, Nvidia, Cheniere Energy And A Health Care Stock: CNBC’s ‘Final Trades’

  • NewsEvette Mitkov

    BioNTech Stock Dips After BNT122-01 Trial Termination

  • News

    QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax

  • Press releaseBusiness Wire

    Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

  • Press releaseGlobe Newswire

    Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

  • Press releaseGlobe Newswire

    A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity

  • NewsVandana Singh

    Why Is Arbutus Biopharma Stock Gaining Friday?

  • NewsSurbhi Jain

    Merck and Moderna's Phase 3 Win Raises the Stakes for BioNTech and Roche (CORRECTED)

  • Press releaseGlobe Newswire

    BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

  • NewsMohd Haider

    Moderna Stock Cools Off After-Hours, Following Massive 177% Cancer Vaccine Rally — Merck, Pfizer and BioNTech Among mRNA Names Trending Tonight

  • NewsEvette Mitkov

    Pfizer Stock Rises Wednesday: What's Going On?

  • NewsVandana Singh

    Why Is BioNTech Stock Surging on Wednesday?

  • Press releaseGlobe Newswire

    BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

  • Press releaseBusiness Wire

    European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

  • Press releaseGlobe Newswire

    European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

  • NewsNamrata Sen

    GOP Congressman Slams JD Vance's Silence Over CDC's $1.24 Billion Pfizer COVID Vaccine Contracts: 'Why Isn’t He Speaking Out'

  • Press releaseGlobe Newswire

    The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution

  • News

    'BioNTech Investor Förtsch Says Founders' Spinout Raises Concerns' - Bloomberg News

  • Press releaseGlobe Newswire

    The Multi-Billion-Dollar Search for Better Glioblastoma Treatments

  • Press releaseGlobe Newswire

    BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • NewsVandana Singh

    BioNTech Slides As Vaccine Sales Drop, Restructuring Plan Takes Shape

  • News

    Earnings Scheduled For May 5, 2026

  • Press releaseGlobe Newswire

    BioNTech Announces First Quarter 2026 Financial Results and Corporate Update

  • NewsAvi Kapoor

    SanDisk, Western Digital, Clorox And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • NewsNamrata Sen

    Elon Musk Questions COVID-19 Vaccine Dosage, Says It Was 'Obviously Too High'

  • NewsHenry Khederian

    Why Is Pfizer Stock Dropping Tuesday?

  • NewsAvi Kapoor

    Serve Robotics Posts Upbeat Q4 Results, Joins Auna, Acacia Research And Other Big Stocks Moving Higher On Wednesday

  • NewsErica Kollmann

    BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls

  • NewsAvi Kapoor

    Dow Jumps Over 300 Points; Kohl's Posts Upbeat Earnings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.